Randomized Placebo-Controlled Trial (RPCT) of Maize/Zinc in Guatemala

NCT00098202 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 420

Last updated 2013-12-17

No results posted yet for this study

Summary

Malnutrition is a serious health problem in the developing world. This study looks at the effects of changing the type of basic food staple (corn) used in Guatemala and infant zinc supplementation on infants' growth, development, and illnesses from infectious diseases.

Conditions

  • Nutrition
  • Pregnancy

Interventions

DRUG

Low phytic acid maize

DRUG

Zinc

Sponsors & Collaborators

  • Global Network for Women's and Children's Health Research

    collaborator OTHER
  • Bill and Melinda Gates Foundation

    collaborator OTHER
  • Fogarty International Center of the National Institute of Health

    collaborator NIH
  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH
  • National Institute of Dental and Craniofacial Research (NIDCR)

    collaborator NIH
  • National Cancer Institute (NCI)

    collaborator NIH
  • RTI International

    collaborator OTHER
  • University of Colorado, Denver

    collaborator OTHER
  • Center for Studies of Sensory Impairment, Aging and Metabolism

    collaborator OTHER
  • Foundation for Alimentation and Nutrition, Central America and Panama

    collaborator OTHER
  • USDA Beltsville Human Nutrition Research Center

    collaborator FED
  • NICHD Global Network for Women's and Children's Health

    lead NETWORK

Principal Investigators

  • Michael Hambidge, MD · University of Colorado, Denver

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-03-31
Completion
2007-04-30

Countries

  • Guatemala

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00098202 on ClinicalTrials.gov